June 2013 Florida Pharmacy Journal by Florida Pharmacy Today

The Official Publication Of The Florida Pharmacy Association JUNE 2013

2013 Legislative Report

Every day, pharmacies depend on PPSC to simplify purchasing, reduce costs and identify new revenue sources – making a significant impact on their bottom line.

Increase Profits

PPSC can help you: EXPAND use of high-profit generics CREATE effective store layout ENHANCE third-party profits CAPTuRE MTM revenue EsTAblisH new business niches INCREASE your overall margins

Independent…But Not Alone. PPSC is Your Partner for Success For more on how PPSC can maximize the potential of your independent pharmacy, visit www.ppsconline.com or call toll-free 888-778-9909.

Board of Pharmacy Licensure Disciplinary Proceedings Compounding Violations, Pharmacy Audit Disputes Mergers and Acquisitions Commercial, Civil and Criminal Proceedings KAHAN ◆ Heimberg, PLC

Pharmacist Attorney Brian A. Kahan, R.Ph., J.D. Licensed Florida Pharmacist and Attorney

STATEWIDE REPRESENTATION 561-392-9000 bkahan@kahanlaw.com 2300 N.W. Corporate Blvd., Suite 123 Boca Raton, FL 33431 The hiring of a lawyer is an important decision that should not be based solely upon advertisements. Before you decide, ask us to send you free written information about our qualifications and experience.

e bl la ai / 7 Av 24

A Pharmacist And A Lawyer

PHARMACY CONSULTING & STAFFING SOLUTIONS Pharmacist & Technician Staffing Pharmacy Management Temporary & Vacation Coverage Open a Pharmacy (Retail & Compounding) Licensing for All States Medicaid & BOP Inspection Preparation Pharmacy Insurances Assistance Policy & Procedures Selling a Pharmacy NO ONE CAN PROVIDE BETTER SERVICE! EPC is Pharmacist Owned and Operated www.epcepc.com (855) 374-1029

florida PHARMACY TODAY Departments 4 Calendar 4 Advertisers 5 President’s Viewpoint 7 Executive Insight 17 Buyer’s Guide

VOL. 76 | NO. 6 JUNE 2013 the official publication of the florida pharmacy association

Features

7 16

2013 FPA Legislative Report Compounding Pharmacies Face Uncertainty with New Regulations

JUNE 2013

FPA Calendar 2013

JUNE 4-5

Board of Pharmacy Meeting Miami

7-14

FPA CE at SEA: Anchorage, Alaska to Vancouver, British Columbia

August 2-4

FSHP Annual Meeting

3-5

Southeastern Officers Conference Nashville, Tennessee

4-7

Southeastern Educational Gatherin Sandestin

Convention Registration Deadline

Deadline for convention hotel registration

13-14 Board of Pharmacy Meeting Orlando

FPA Leadership Retreat

24-25 FPA Council, Committee and Board of Director Meetings

JULY 9

Florida Pharmacy Council Orlando

10-14 FPA Annual Convention JW Marriott, Grande Lakes 19

Deadline for Southeastern Gatherin’ in Destin

FPA Governmental Affairs Committee Orlando

SEPTEMBER 1

Deadline for receipt of officer nominations

7-8

FPA Law and Regulatory Conference Ft. Lauderdale

Last day to renew “PS” pharmacist licenses

Mission Statements: of the Florida Pharmacy Today Journal

The Florida Pharmacy Today Journal is a peer reviewed journal which serves as a medium through which the Florida Pharmacy Association can communicate with the profession on advances in the sciences of pharmacy, socio-economic issues bearing on pharmacy and newsworthy items of interest to the profession. As a self-supported journal, it solicits and accepts advertising congruent with its expressed mission.

of the Florida Pharmacy Today Board of Directors

The mission of the Florida Pharmacy Today Board of Directors is to serve in an advisory capacity to the managing editor and executive editor of the Florida Pharmacy Today Journal in the establishment and interpretation of the Journal’s policies and the management of the Journal’s fiscal responsibilities. The Board of Directors also serves to motivate the Florida Pharmacy Association members to secure appropriate advertising to assist the

Journal in its goal of self-support.

For a complete calendar of events go to www.pharmview.com CE CREDITS (CE cycle) The Florida Board of Pharmacy requires 10 hours LIVE Continuing Education as part of the required 30 hours general education needed every license renewal period. Pharmacists should have satisfied all continuing education requirements for this biennial period by September 30, 2013 or prior to licensure renewal. Technicians will need to renew their registration by December 31, 2014. *For Pharmacy Technician Certification Board Application, Exam Information and Study materials, please contact the FPA office. For More Information on CE Programs or Events: Contact the Florida Pharmacy Association at (850) 222-2400 or visit our Web site at www.pharmview.com

Advertisers EPC........................................................................ 2 HCC...................................................................... 3 Kahan Heimberg, PLC............................... 2 PPSC...................................................................... 2

CONTACTS FPA — Michael Jackson (850) 222-2400 FSHP — (850) 906-9333 U/F — Dan Robinson (352) 273-6240 FAMU — Leola Cleveland (850) 599-3301 NSU — Carsten Evans (954) 262-1300 DISCLAIMER Articles in this publication are designed to provide accurate and authoritative information with respect to the subject matter covered. This information is provided with the understanding that neither Florida Pharmacy Today nor the Florida Pharmacy Association are engaged in rendering legal or other professional services through this publication. If expert assistance or legal advice is required, the services of a competent professional should be sought. The use of all medications or other pharmaceutical products should be used according to the recommendations of the manufacturers. Information provided by the maker of the product should always be consulted before use. 4 |

Flo r i d a P h a r m a c y To d a Y

E-mail your suggestions/ideas to dave@fiorecommunications.com

The President’s Viewpoint GOAR ALVAREZ Pharm.D, FPA President

President’s Annual Report to Members

he year has come and gone and I can truly say that it has been my very distinct honor and my privilege to have served as your president. As I look back, I can say with pride that much has been accomplished and much has been put in motion for years to come. In my inaugural address, in my call for unity, I pledged that I would work to help unify our profession. Early on, I reached out to FSHP leadership and I believe, have succeeded in creating a unity between our organizations that I have not seen in at least 20 years. This new unity was pivotal to our mutual successes on the legislative front. I shall continue to work to strengthen our unity for the benefit of our profession as a whole and it is my hope that this is only the beginning of our collaboration. Likewise, I reached out to the deans of the colleges of pharmacy in our state and received overwhelming support. The number of students and pharmacists that participated at the Capitol during Florida Pharmacy Legislative Day and Health Fair this year was an impressive 437 (a 40% increase over last year). These students and pharmacists performed just shy of 1,000 health screenings and promoted our profession to legislators and the public alike. This sea of “white coats” took every opportunity to promote our profession and to educate our legislators that “pharmacists are very accessible, highly educated and well-trained health care providers ready to take on new roles as fully integrated members of the healthcare team.” This year, the councils of the Florida Pharmacy Association were purposely comprised of experienced prac-

titioners, students from every college of pharmacy, and pharmacy technicians. The purpose was to provide experience and know-how, enthusiasm and energy, and broad consensus among all members we represent. As president, I wanted to ensure that each Council had a student from each school serving on

The number of students and pharmacists that participated at the Capitol during Florida Pharmacy Legislative Day and Health Fair this year was an impressive 437 (a 40% increase over last year). said council. I wanted to make sure that we had our students share their hopes and aspirations for the future of our profession and wanted our experienced practitioners to mentor and guide these new “leaders in training.” The Council chairs had short-term and long-term goals. I am proud to report on some of the successes of their teams. One of my goals during my presidency was to communicate to pharmacists throughout the state that our profession is changing, that we are

Goar Alvarez, Pharm.D 2012-2013 FPA President

evolving and that we must embrace these challenges and opportunities and transform the practice of pharmacy. It was also my goal to have meaningful education and training available to our members that would empower them to be more practice ready for this new health care paradigm shift. This year we provided a total of seven conferences throughout the state accounting for over 105 CE credits in a variety of subject matter to help you get to the next level. Educational Affairs Council Chair Angela Clauson, Pharm.D., and her team were busy working with Tian Merren, MS., Pharm.D, FPA Director of Continuing Education, in putting together this array of superb programs. Dr. Clauson was also charged with developing our first “anytime/anywhere” online CE offering. Our popular “regulatory and law update” CE will be the first program offering to be launched in JUNE 2013

FPA Staff

Executive Vice President/CEO Michael Jackson (850) 222-2400, ext. 200

Director of Continuing Education Tian Merren-Owens, ext. 120 Controller Wanda Hall, ext. 211

Educational Services Office Assistant Stacey Brooks, ext. 210 Coordinator of Membership Christopher Heil, ext. 110

Florida Pharmacy Today Board Chair............................................. Jennifer Pytlarz, Brandon Vice Chair...................Don Bergemann, Tarpon Springs Treasurer...............................Stephen Grabowski, Tampa Secretary.........................Stuart Ulrich, Boynton Beach Member..................................... Joseph Koptowsky, Miami Member..............................Rebecca Poston, Tallahassee Member.............................. Carol Motycka, St. Augustine Member....................................Cristina Medina, Hollywood Member................................. Norman Tomaka, Melbourne Member..............................Verender Gail Brown, Orlando Executive Editor.........Michael Jackson, Tallahassee Managing Editor.........................Dave Fiore, Tallahassee

This is a peer reviewed publication. ©2013, FLORIDA PHARMACY JOURNAL, INC. ARTICLE ACCEPTANCE: The Florida Pharmacy Today is a publication that welcomes articles that have a direct pertinence to the current practice of pharmacy. All articles are subject to review by the Publication Review Committee, editors and other outside referees. Submitted articles are received with the understanding that they are not being considered by another publication. All articles become the property of the Florida Pharmacy Today and may not be published without written permission from both the author and the Florida Pharmacy Today. The Florida Pharmacy Association assumes no responsibility for the statements and opinions made by the authors to the Florida Pharmacy Today. The Journal of the Florida Pharmacy Association does not accept for publication articles or letters concerning religion, politics or any other subject the editors/ publishers deem unsuitable for the readership of this journal. In addition, The Journal does not accept advertising material from persons who are running for office in the association. The editors reserve the right to edit all materials submitted for publication. Letters and materials submitted for consideration for publication may be subject to review by the Editorial Review Board. FLORIDA PHARMACY TODAY, Annual subscription - United States and foreign, Individual $36; Institution $70/year; $5.00 single copies. Florida residents add 7% sales tax. Florida Pharmacy Association

610 N. Adams St. • Tallahassee, FL 32301 850/222-2400 • FAX 850/561-6758 Web 6 Address: | Flo rhttp://www.pharmview.com i d a P h a r m a c y To d a Y

this format. Work has already begun in the development of this lecture series. Thank you both for your hard work. Professional Affairs Council Chair, Student Pharmacist Jennifer Raquipo, was assigned the task of identifying ways and tools that would empower our members to evolve successfully as healthcare providers. Her charges were to identify unique roles for pharmacists in the evolving healthcare system and discuss what might “push” our profession forward to the next level in our evolution. I was glad I made the decision to name a student pharmacist to chair this important council as we were able to benefit from the student perspective of how they view the role of the pharmacist of the future. Her vision, tempered with the seasoned members on her team, was the right choice for this council. Jennifer also made history as the first student Chair of a council on the FPA. I am very proud of her and of her longterm commitment. She has held leadership roles at the FPA for a number of years as a council member. Organizational Affairs Council Chair, Carmen Aceves-Gordon, BPharm. MS., was charged with ensuring that our organizational structures at the FPA continue to serve the needs of our members. She was tasked with the review and recommendations to revise the Constitution, bylaws, personnel policies, and operational policies. She was also charged with developing strategies to revitalize, support and strengthen local unit associations. I am always in awe of Carmens’ skills and thankful for her leadership and support over the years. Angela Garcia, Pharm.D., MPH, as Chair of the Public Affairs Council and with her team, were charged to work on materials that showed the “value of the pharmacist” to the public. She and her team aptly accomplished this task by coordinating with student pharmacists throughout the state in developing posters depicting the role of the pharmacist in a variety of public health initiatives. These posters were showcased at Legislative Days and are available to members wishing to utilize them. Dr. Garcia was also charged

with developing a streaming video depicting “what pharmacists really do.” This is a work in progress. Thank you Dr. Garcia and council team members and students for an incredible job well done. Membership Council Chair Don Bergemann, BPharm., MBA, was charged with the monumental task of identifying our membership markets and stratification. The goal is to develop a “value-proposition” model for members/prospective members. He was also to work on developing a “welcome-kit” or calling tree/webinar to guide and engage new members quickly into the FPA family. In response to his charges, Don has put together a report making suggestions regarding the #1 Club as well as a strategic membership directive “white paper” with recommendations for the Board of Directors to consider. Thank you for your service and support, Don. Humberto Martinez, BPharm., Chair of Governmental Affairs Council, was charged with developing our legislative priorities list and to align these with available resources. He was also charged to work with our sister organization FSHP in creating a “joint” legislative priorities list. In concert with FPA counsel and our lobbyist, he and his team helped draft “talking points” supporting the FPA positions on proposed legislation. The Health Fair Ad-Hoc Committee co-chaired by Angela Garcia, Pharm.D., and Suzanne Kelly, BPharm., was responsible for the coordination of the health fair at the Capitol. From inventory and ordering of supplies, procurement of equipment, training students and pharmacists on equipment and much, much more. This year, all this seemed to happen without a hitch. I am very grateful to both Angela and Suzanne for making this appear effortless. I know better and am very aware of all the hard work that goes into this endeavor. I would also like to thank Humberto Martinez for coordinating the Miami-Dade Health Fair and assisting at the Capitol with training of students and pharmacists. We had many successes this year. See "Viewpoint", continued on page 15

Executive Insight by michael jackson, RPh Michael Jackson, BPharm, EVP & CEO, Florida Pharmacy Association

2013 FPA Legislative Report

t seems that every legislative session has its own unique personality with many challenges as well as opportunities. We can say for sure that given the limited resources available to the FPA we were successful in getting a number of favorable issues advanced and stopping others from becoming law as recommended by both FPA leadership and you as pharmacy stakeholders. We identified over 900 bills in the Florida House and nearly 1,000 bills filed in the Florida Senate. A little over 200 bills made it through the complex process and are either on their way to the governor’s desk or are being signed as we go to press with this report. This is not unusual as it generally is difficult to revise Florida laws and is designed purposefully to be that way. This report contains a review of the issues discussed by the Legislature that may be of interest to the members. Some have been signed into law by the governor while other bills are being reviewed for his signature. A final report will be provided at the FPA annual meeting July 7 – 14, 2013. Some of the issues we have been monitoring that have been approved by the Florida House and Senate are as follows:

Substitution of Biological Drugs (HB365) – This legislation allows for the interchanging of biosimilar and biological drugs under the following conditions: ■■ The FDA has determined that the substitute biological product is biosimilar to and interchangeable for the prescribed biological product ■■ Adds biologicals, biosimilars and biosimilar interchangeables to hospital formulary lists ■■ The prescribing health care provider does not express a preference

against substitution in writing, verbally, or electronically ■■ The pharmacist notifies the person presenting the prescription of the substitution in the same manner as provided in existing laws (465.025) ■■ The pharmacist maintains a written record of the substitution for at least 2 years ■■ Hospital pharmacists can comply with patient notification by noting

A little over 200 bills made it through the complex process and are either on their way to the governor’s desk or are being signed as we go to press with this report. in the patient’s medical record The Board of Pharmacy must maintain a web site list of interchangeable biologicals and biosimilars drugs ■■ Signed by Governor Scott What does this mean for FPA members? – Currently, the FDA has not defined how biological and biosimilar drugs can be interchanged. This law appears to create a way for pharmacists to do that similarly to how generic drugs are interchanged today. There are few if any biosimilar drugs on the market here in the U.S., however, the FPA understands that there are some in the development pipeline. Medicaid Fraud (HB939) – Certain ■■

Michael Jackson, B.Pharm

provisions of Florida Medicaid laws have been revised to do the following: ■■ Require a report to be filed within 30 days when there is a change of principal provider including any officer, director, agent, managing employee, affiliated person, partner or shareholder ■■ Retain the number of years that Medicaid records should be kept at 5 years ■■ Licensed hospitals, nursing homes, hospices and ALF principals defined in 408.803 would no longer be exempted from some fraud provisions ■■ Revised current authority for the Agency to terminate providers if they are convicted of certain criminal offenses related to the practice ■■ Voluntary relinquishment of Medicaid provider number or license after receiving a notice of agency action will not stop sanction efforts ■■ Limits what records can be used to contest a finding of overpayment or JUNE 2013 |

2013 FPA Board of Directors The Florida Pharmacy Association gratefully acknowledges the hard work and dedication of the following members of the FPA leadership who work deligently all year long on behalf of our members.

Bob Parrado.............................................................................. Chairman of the Board Goar Alvarez ................................................................................................FPA President Terry Gubbins............................................................................................ President Elect Betty Harris ............................................................................................................Treasurer Eric Alvarez.................................................Speaker of the House of Delegates Gary Koesten.................................Vice Speaker of the House of Delegates Preston McDonald, Director............................................................................ Region 1 Michael Hebb, Director ......................................................................................Region 2 Eva Sunell, Director ..............................................................................................Region 3 Raul N. Correa, Director ...................................................................................Region 4 Jeffery Parrado, Director ...............................................................................Region 5 Scott Tomerlin, Director.....................................................................................Region 6 Paul Rohrbaugh, Director.................................................................................. Region 7 Raul Gallo, Director.................................................................................................Region 8 Paul Elias, Director.................................................................................................Region 9 Constance Hogrefe.............................................................................. President FSHP Michael Jackson........................................Executive Vice President and CEO

Florida Pharmacy Today Journal Board Chair......................................................Jennifer Pytlarz, jlc_rxdoc@hotmail.com Vice Chair......................................................... Don Bergemann, don@bceinfo.com Treasurer....................Stephen Grabowski, sgrabowski@seniormmc.com Secretary...................................................................Stuart Ulrich, Stuarx@aol.com Member.................................................Joseph Koptowsky, docjik1215@aol.com Member........................Rebecca Poston, rebecca_poston@doh.state.fl.us Member....................................................... Carol Motycka, motycka@cop.ufl.edu Member........................................................Cristina Medina, cmmedina@cvs.com Member................................................................Norman Tomaka, FLRX9@aol.com Member................... Verender Gail Brown, brownvgrx4304@hotmail.com Executive Editor................Michael Jackson, mjackson@pharmview.com Managing Editor...................Dave Fiore, dave@fiorecommunications.com

8 |

Flo r i d a P h a r m a c y To d a Y

sanction by the Agency (only contemporaneous records can be used) ■■ Provider overpayments will have to paid back to AHCA within 30 days. (Interest accrues from date of final determination) ■■ Additional protections from civil liability were added for reporting fraud ■■ Allows payment for telecommunication services for Florida licensed physicians ■■ Signed by Governor Scott What does this mean for FPA members? – This change in Florida laws related to Medicaid gives the Agency for Health Care Administration additional authority over provider behavior. Members will have to continue their efforts to maintain good records regarding the care of Medicaid recipients. Members will also need to make sure that any changes in prescription department managers are reported promptly. Workers Compensation (SB662) – This legislation seeks to further define reimbursement for prescription medications for workers compensation patients. If signed into law by Governor Scott this bill: ■■ Attempts to clarify pricing of repackaged drugs for workers compensation prescriptions ■■ Sets reimbursement rates of dispensing MDs to 112.5% of AWP and an $8.00 dispensing fee for repackaged drugs ■■ Requires use of original manufacturer’s NDC code for repackaged drugs ■■ Would disallow dispensing practitioners from possessing drugs billed to workers compensation that have not been paid for within 60 days of dispensing. ■■ Signed by Governor Scott What does this mean for FPA members? – Prescription drugs for workers compensation patients dispensed by physicians are higher in cost than those dispensed by pharmacies. Florida’s workers compensation prescription costs are higher than many states. This again could be contributed to physician dispensing. This bill seeks to define reimbursement of workers compensation prescriptions dispensed by dispensing practitioners. Though the bill does not level the play-

ing field between pharmacy and physician dispensing practitioners, it does establish a reimbursement ceiling that was not present before. Payment Systems for Hospitals (SB1520) ■■ Creates a DRG based payment systems for hospitals ■■ Rates are to be recalculated annually ■■ Agency to set outpatient reimbursement services rates ■■ Funds a statewide Medicaid residency program for primary care providers using Medicaid per diems ■■ Funding allocated for Medical residents ■■ Signed by Governor Scott What does this mean for FPA members? – DRGs or “diagnostic related groups” is not a new concept in payment for hospital services. DRG is a type of prospective payment system for reimbursing hospitals. DRGs classify an inpatient stay into a group based on a patient’s diagnoses, gender, age, and other factors, which can include hospital case mix and overall wellness or acuity of the hospital’s overall patient population. Groups of related diagnoses are designed to provide a stable and fairly predictable indication of the resources needed for treating a particular patient. This type of system is used in the federal Medicare program and seeks to tailor reimbursement more closely to actual costs of treatment for each individual patient. Hospitals with a significant Medicaid census may see their reimbursement change. This could affect health care support services such as inpatient pharmacy budgets. Impaired Practitioner Consultant (SB604) – This bill was originally filed to give the Department of Health contracted impaired practitioner consultant access to the PDMP program database, however that bill was amended to now only allow expansion of the Department of Health’s ability to defend the impaired practitioner consultant if there is a claim. What does this mean for FPA members? – This issue will likely have little bear-

ing on FPA members as it is primarily a bill to address Department of Health internal policies. Physician Assistant Ordering of Medications (SB398) ■■ Clarifies that a PA can order medications in a hospital under the direction of a physician ■■ The House version that appeared to clarify that the PA can dispense as an agent of the physician had that section removed ■■ Signed by Governor Scott What does this mean for FPA members? – Currently, physician assistants have been ordering medications in hospitals based upon authority granted to them by the facility’s policies and procedures. This practice has been called into question by some facility risk managers indicating the vague language in the PA practice act. This bill clarifies physician assistant authority for issuing orders in licensed hospitals. Members should not see any changes in those facilities. Public and Private Schools and Epinephrine (SB284) ■■ Allows public schools to order and maintain epinephrine auto-injectors for their students ■■ Epinephrine must be maintained in a locked location ■■ School district must adopt protocol with licensed MDs ■■ Can be administered by trained school personnel or by the student authorized to self-administer ■■ School district employees and physicians who signed the standing protocol not liable under certain circumstances ■■ Signed by Governor Scott What does this mean for FPA members? – This bill will have little to no impact on FPA members, however, it would be a good idea for pharmacists to connect with public and private school districts and stress the importance of proper storage and maintenance of these medications. Members could educate school administrators on issues such as expiration dating, recalls or other similar matters.

Florida Controlled Substance Act (SB294) ■■ Revises the list of controlled substances in schedule I (addition of some 20 or more items) ■■ Adds synthetic cannabinoids, cathinones and phenethylamines ■■ Unlawful acts related to these substances subject to arrest and prosecution ■■ Signed onto law by Governor Scott What does this mean for FPA members? – This legislation came about by the need to address emerging chemical changes with abused substances by adding to the list of Florida schedule I controlled substances. Members will need to make sure that any chemicals in their pharmacies that are added to schedule I are handled according to this new revision to Florida law. You can see the list of new chemicals that have been added by going to Senate bill 294 passed during the 2013 legislative session. Optometrist Prescribing (HB239) Expands optometrist prescribing authority to include oral and topical ophthalmic agents ■■ Creates a certification training program jointly provided by the Florida Medical Association and the Florida Osteopathic Medical Association ■■ Restricts the prescribing or administration of controlled substances to only III, IV or V ■■ Allows optometrists to administer schedule III, IV or V oral analgesics for the relief of pain due to conditions or the eye or its appendages. ■■ Adverse incidences required to be reported ■■ Signed into law by Governor Scott What does this mean for FPA members? – Pharmacists may now dispense from an expanded list of medications prescribed by certified optometrists. This includes not only topical drugs used to treat and diagnosis the eye by optometrists but also oral drugs that are used for the same purpose. Members may need to be aware that optometrists will need to be credentialed to have this new prescribing authority. It is unknown whether or not there is an obli■■

JUNE 2013

FLORIDA PHARMACY FOUNDATION SPONSORS

Casino Night Fundraiser Come and join your friends at Casino Night, a glamorous evening of fun, playing Black Jack, Poker, Craps and the numbers game of Roulette. Big Prizes will be awarded. The proceeds will benefit the goals of the Foundation to further the need of providing student scholarships, Adopt-aStudent program, Hardship Fund, Demonstration Project Grants and Alton Tower Philanthropy Award. When: July 12, 2013 Where: J.W. Marriott Grand Lakes, Orlando Time: 8:00 P.M. - 11:00 P.M. Cost: $70 per Person (You must be 18 years or older to attend) Kids Night Out available - check with hotel

INCLUDES:

1,000 PLAYING CHIPS (Re-buy available) CASH BAR | BIG PRIZES HORS d’OEUVRES

A COPY OF THE OFFICIAL REGISTRATION AND FINANCIAL INFORMATION MAY BE OBTAINED FROM THE DIVISION OF CONSUMER SERVICES BY CALLING TOLL-FREE 1-800-4357352 WITHIN THE STATE. REGISTRATION DOES NOT IMPLY ENDORSEMENT, APPROVAL, OR RECOMMENDATION BY THE STATE.

PAYMENT INFORMATION Check enclosed for Please charge my: ❑ Visa

Casino Night: $70 per person made payable to the Florida Pharmacy Foundation

tickets, in the amount of $ ❑ MasterCard

Card number

for

tickets, in the amount of $ Security Code

Expiration date

Signature Signature Printed Name Address City

State

Work Phone

Home Phone

Zip

PayPal available at www.flpharmfound.org Florida Pharmacy Foundation | 610 N. Adams St, Tallahassee, FL 32301 | (850) 222-2400 | Fax (850) 561-6758 10

Flo r i d a P h a r m a c y To d a Y

gation on the pharmacist to verify this new prescribing authority prior to dispensing. Waiver of Licensure Fees for Veterans (SB160) ■■ Exempts initial licensure fees for honorably discharged veterans ■■ Veteran must apply within 24 months of discharge ■■ May have an insignificant negative fiscal impact on DOH ■■ 1.6 million veterans living in Florida ■■ Signed by Governor Scott What does this mean for FPA members? – FPA member pharmacists and technicians generally already have a Florida license and as such this bill will have an insignificant impact. Pharmacists and pharmacy technicians who have been recently discharged honorably and are eligible for licensure within 24 months of that discharge will not have to pay their initial fees. Unfortunately, this may not help recent discharged veterans who must begin their six years of pharmacy school training. It possibly could help pharmacy technicians who complete their Board approved training program within the 24 month period. Discharged veterans who are pharmacists and are transferring their licenses to Florida may be eligible for this waiver of licensure fees. Revision of Accreditation Standards (HB1071) ■■ Removes a number of references to “Joint Commission” in several sections of Florida laws ■■ May allow for alternative accreditation organizations for facilities and services ■■ Accreditation organizations must incorporate licensure regulations required by Florida ■■ Passed Florida House and Senate ■■ Signed by Governor Scott What does this mean for FPA members? - The Joint Commission (TJC), formerly the Joint Commission on Accreditation of Healthcare Organizations (JCAHO) and previous to that the Joint Commission on Accreditation of Hospitals (JCAH) is a United States-based nonprofit tax-exempt 501(c) organization that accredits more than 19,000 health

care organizations and programs in the United States. A majority of state governments have come to recognize Joint Commission accreditation as a condition of licensure and the receipt of Medicaid reimbursement. Surveys (inspections) typically follow a triennial cycle, with findings made available to the public in an accreditation quality report on the website. Pharmacists

What does this mean for FPA members? – For the past several years the Florida Legislature inserted in the budget language that required state employees to get their maintenance medications processed through the state’s contracted mail order provider after the third fill. It is possible that though the mail order language is still listed in the budget, SB1802 or other similar legislation,

A final report will be provided at the FPA annual meeting July 7 – 14, 2013. working in hospitals or similar facilities could see alternate accreditation entities surveying their facilities rather than the Joint Commission. Vo l u n t e e r H e a l t h S e r v i c e s (HB1093) ■■ Allows health care providers to receive continuing education credits (up to 8 hours) for pro bono services ■■ Pro bono services should be performed for a state agency under a government contractor ■■ Services should be provided to the indigent ■■ Signed by Governor Scott What does this mean for FPA members? – On occasion, governmental contractors may solicit the services of health care providers to provide volunteer and uncompensated health care services to low-income individuals. It is possible that pharmacists providing these services could qualify for this continuing education credit. State Employee Mail Order Program (SB1500 – State Budget) ■■ Mail order language found on page 390, paragraph item #6 ■■ Appears to be renewing the current state employee mail order program ■■ SB1802 has softened the sting of this provision perhaps by setting the conditions under which this mail order program can proceed ■■ Signed by Governor Scott

which also passed the House and Senate, may provide some relief to the language in the budget and the mail order requirement may end for this fiscal year. More on this will be shared at the 2013 annual meeting and convention this summer. Medical Malpractice Insurance (SB468) ■■ Attempts to deregulate malpractice insurance rate setting ■■ Malpractice insurance carriers would not be subject to rate reviews by the office of insurance regulations ■■ Exemption for physicians ■■ Pharmacists and technicians added later in the session ■■ Signed by Governor Scott What does this mean for FPA members? – Some insurance providers are exempted from having to file with the Office of Insurance Regulation (OIR) for changes to their premium rates. This means that insurance carriers that are exempted could have more flexibility to change their premium rates at will. This bill was designed to add malpractice insurance carriers as entities who would not have to have their rates reviewed by OIR. Removed from this deregulation of malpractice carriers included licensed dentists, physicians, osteopathic physicians, chiropractic physicians and podiatric physicians. This means that pharmacist liability insurance carriers

could change their rates at will without any intervention from the Office of Insurance Regulation. The FPA was successful in adding in pharmacists and pharmacy technicians to this bill which would require insurance carriers to have their rates reviewed prior to implementation. Cancer Treatment Fairness Act (HB1159) ■■ Requires insurance coverage of oral cancer medications ■■ Cost sharing requirements for oral cancer medications must not be less favorable than cost sharing requirements for IV or injectable medications ■■ Does not allow the insurance plan or HMO to modify their policies to avoid compliance on the effective date of this bill ■■ Does not allow for the plan or HMO to offer incentives or penalize patients for accepting less protection required by this bill ■■ Does not allow an insurance plan or HMO to penalize a health care practitioner for recommending or providing care required by this bill ■■ Does not allow the insurance plan or HMO to provide incentives to practitioners to provide care that is not in compliance with this bill ■■ Will not allow for the change in classification of IV or injectable cancer treatment or increase the amount of the cost share in effect on the effective date of the bill ■■ Signed by Governor Scott What does this mean for FPA Members? – The Association was amazed to learn that copays or cost shares paid by patients for oral cancer medications were in some cases higher than what patients had to pay for IV or injectable therapy. Additional language was included in the bill that removed things like patient or provider penalties or incentives to steer therapy based upon coverage for cancer patients. Members treating patients on cancer medications may see changes in patients’ copays or cost shares.

Flo r i d a P h a r m a c y To d a Y

Funding of the PDMP Program (HB1159) – Senate bill 1192 and House bill 831 were filed to address a number of issues related to Florida’s prescription drug monitoring program (PDMP). This program can only be funded with voluntary contributions to a foundation authorized by the Florida Legislature. No manufacturer grants or state funds were allowed to support the PDMP program. SB1192 and HB831 were published to allow state and or manufacturer funding. Neither bill was able to get to the governor’s desk for signing into law. An amendment, however, was inserted into House bill 1159 related to cancer treatment that provided $500,000 in funding for the PDMP for fiscal year 2013-2014. Absent this allocation by the Legislature, the PDMP would have to wind down its operations. The FPA reached out to members of the Florida Legislature and asked for their support. Association leadership even initiated a fundraising campaign at our law conference in Tampa on April 20, 2013. What does this mean for FPA Members? – Had this program not received this funding from the Legislature, there would likely be a requirement for pharmacies to report data to a prescription drug monitoring program database that would be unfunded and have no resources to operate. Members may also find that they would have been unable to query the database for patients’ dispensing history should the PDMP program stop operating. The Association has learned that the PDMP program had only about a month or so of operating funds. This budget allocation will keep things going until the Legislature implements its 2014 budget.

Disposable and Reusable Bags (SB722, HB957) ■■ Would have facilitated uniform local ordinance rules on disposable bags for merchants ■■ Optional for charging a fee for reusable bags ■■ Required a fee to be charged for recyclable bags ■■ 50% of fees collected go to school districts ■■ Merchant could have kept up to the other 50% of the fees ■■ Reports would have been required to be filed with the state

Bills of Interest Not Adopted By the Florida Legislature As mentioned earlier, just over 10% of all filed bills ever get to the Governor’s desk. Some of those may be victim of the veto pen, which means that many of the issues debated by Florida’s policymakers never get through a very complex process. A sampling of some of the many issues that the FPA was monitoring that did not pass includes the following:

Audits of Phar mac y Records (HB791, SB1358) ■■ Attempted to expand existing auditing standards for Medicaid and make them applicable to all third party programs ■■ Was supposed to revise F.S. 465.188 ■■ Found favorable in Senate Health Policy

“W ho Can Be Called Doctor ” (SB612, HB805) ■■ Created grounds for disciplinary action for a licensee under F.S. 464 to use the “Dr.” designation when providing or advertising health care services. ■■ Penalty would have been a third degree felony ■■ Not applicable to pharmacists Needle and Syringe Exchange Program (SB808, HB735) ■■ Created a free needle and hypodermic syringe and needle exchange pilot program in Miami-Dade ■■ Program to be housed within the Department of Health ■■ User would get one needle and syringe for each one exchanged ■■ Department of Health would have to provide educational materials on HIV AIDS ■■ Possession of needles and syringes under this program would not have been a violation ■■ Program would have ended July 1, 2018

Medical Cannabis (SB1250, H1139, S1214) ■■ Labeled the Cathy Jordan Medical Cannabis Act ■■ 133 page bill would have defined the medical use of cannabis ■■ The Department of Business and Professional Regulation would have been the designated agency that regulates medical cannabis farms ■■ Bill described a “dispensary” as being a facility licensed under Florida Statutes 499 Required Coverage for Telemedicine Services (SB898, HB499) ■■ Would have required health insurers, corporations, and health maintenance organizations issuing certain health policies to provide coverage for telemedicine services ■■ Would have prohibited the exclusion of telemedicine cost coverage solely because the services were not provided face to face ■■ Would have prohibited the imposition of certain dollar and durational coverage limitations or copayments, coinsurance, or deductibles on telemedicine services unless imposed equally ■■ Would have provided coverage under the state plan or a waiver for health home services provided to eligible individuals with chronic conditions Changes to Licensing Requirements (SB1334) ■■ Would have removed the requirement for the Department of Health to issue wallet and wall ID cards ■■ Would have relocated CE tracking language to a different section of Florida law ■■ Would have required the Department of Health to integrate the CE tracking and licensing systems ■■ Would have required licensees to provide current email address ■■ Mailed and emailed notices from the DOH would be considered sufficient notice ■■ Adding Growth Hormones to Schedule III ■■ Proposed legislation would have added human chorionic gonadotropin and other similar growth hor-

mone drugs to Florida’s schedule III controlled substance list. Change of Pharmacy Technician Ratio (HB671, SB818) ■■ Would have significantly raised the number of technicians that a pharmacist could supervise beyond the current Florida law limit of three. ■■ Would have allowed the supervision of more than six technicians if permitted by guidelines adopted by the Board of Pharmacy ■■ Opposed by the FPA and FSHP ■■ Passed by House but stalled in the Senate FPA IS ON THE MOVE We hope that you found this report informative and a synopsis of the investment that each of you has made in maintaining your membership in the Florida Pharmacy Association. There will continue to be no shortage of issues pending that need to be dealt with. The FPA has a wealth of student, technician and pharmacist volunteers that have graciously given of their time and talents to fulfill the mission of the FPA. It is no secret that this profession is in transformation. It will evolve into a practice model that can be of tremendous benefit to consumers but to do that we must continue the revolution against policies that harm patient access and devalues what our industry can bring to the health care table. We are all gladiators in a fight to ensure the viability of this profession for years to come. Thank you for your commitment and your support. n

JOIN TODAY!

Florida Pharmacy Association

JUNE 2013

FPA Officer and Director Nominations Although we have just finished the election for a president-elect and directors for the odd numbered regions to be installed at the 2013 annual meeting, it is time to start thinking about nominees for the 2014 election since the nomination deadline is September 1 of this year (9/1/13). As the form below indicates, this year we will need candidates for president-elect and directors for the even numbered regions. Please note that you may nominate yourself. CALL FOR FPA OFFICER AND DIRECTOR NOMINATIONS for 2014 Elections The FPA By-Laws specify that any subdivision or any member in good standing may nominate one person for the office of President-Elect and one person for the office of Treasurer. A President-Elect shall be elected every year and shall assume the duties of the President on the last day of the annual meeting of the year following election as President-Elect. The treasurer shall serve a two year term and may succeed to one consecutive term of office in that capacity. Nominees must be Florida registered pharmacists in good standing with the Florida Pharmacy Association and the Florida Board of Pharmacy. Nominees for president-elect should have a good understanding of how the Association functions and should be current on the issues impacting pharmacy. Nominees for treasurer should have good analytical skills and experience and ability in financial management and budget preparation. There are nine regional Board Directors who shall serve two year terms. Nominees must be a Florida registered pharmacist in good standing with the Florida Pharmacy Association and the Florida Board of Pharmacy. Additionally, Board Directors must be a member of at least one the FPA Unit Associations within their region. Board Directors terms are staggered such that even numbered regions shall be elected in even numbered years and odd numbered regions shall be elected in odd numbered years. All newly elected Board of Directors Regional Directors shall take office on the last day of the annual meeting, and shall continue in office until the last day of annual meeting of the second ensuing year.

FPA CANDIDATE NOMINATION FORM I AM PLEASED TO SUBMIT THE FOLLOWING NOMINATION: NAME: ADDRESS:

FOR THE FOLLOWING OFFICE:

(Nomination Deadline September 1, 2013)

q President-Elect q Board Director Region 2 Region 4 Region 6 Region 8

NOMINATED BY: NAME: DATE SUBMITTED: SIGNATURE:

MAIL NOMINATIONS TO: Election Nominations, Florida Pharmacy Association, 610 N. Adams St., Tallahassee, FL 32301 (850) 222-2400 FAX (850) 561-6758 DEADLINE FOR NOMINATIONS IS SEPTEMBER 1, 2013

Flo r i d a P h a r m a c y To d a Y

"Viewpoint", continued from page 6

In my call to action, to protect, preserve and promote the profession, when called upon, YOU acted. Because of YOUR commitment and involvement we fought and won what seemed at times to be insurmountable odds. The FPA, together with FSHP and FIPN helped defeat the technician expansion ratio, which would have expanded the pharmacist to technician ratio from 1:3 to 1:6 plus. The memberships from both the FPA and FSHP overwhelmingly voiced patient safety concerns of the proposed legislation. Discussions with hundreds of pharmacists, student pharmacists and technicians alike voiced similar concerns. We helped remove language that would have required pharmacists to notify physicians each time a biological (biosimilar) was substituted. We removed physician assistant dispensing language from proposed legislation. We opposed “who can be called doctor” language which would have disallowed pharmacists and other non-physician health care providers from being called doctor regardless of their degree. We supported funding for the PDPM (Prescription Drug Monitoring Program) and funding has been extended through at least next year. We fought state employee mandatory mail order and at this writing it appears that language requiring mandatory mail will be removed, etc. I thank each of you who fought the fight. As President, I represented you at the Capitol as well as at a number of Board of Pharmacy meetings. I was invited and was honored to represent the FPA at Palm Beach Atlantic (PBA) College of Pharmacy on three distinct occasions. I was also honored to address the students and faculty at Nova Southeastern University (NSU) on multiple occasions and was invited to administer the “Oath of the Pharmacist” to the NSU 2013 graduating class. I attended quarterly FPA Board of Directors and Council meetings as well as quarterly Budget and Finance committee meetings. I participated in a significant number of FSHP Board of Directors meetings and conference calls as well as a number of Legislative Affairs Committee conference calls. I participated on a number of

committee and sub-committee conference calls throughout this year. Although I would like to see all pharmacists, students and technicians in the state become members of the FPA, I am happy to report that this year we had a 12% increase in membership as compared to the same time last year. We also had a very significant student pharmacist membership increase. When visiting some of the colleges of

The memberships from both the FPA and FSHP overwhelmingly voiced patient safety concerns of the proposed legislation. pharmacy at which I was invited to speak, I emphasized the importance of joining and staying involved in professional organizations at the local, state and national levels and that this should begin as students. Being able to be aware of what is happening in your profession and having the platform to have your voice heard is invaluable. That is the true value of membership in the Florida Pharmacy Association. I am also aware of many instances where faculty and administration were involved in reinforcing and encouraging leadership roles among their students, including membership in the FPA and other organizations. The elite #1 Club also seems to be revitalized showing a number of new members that will be installed at the 2013 annual convention in Orlando. Let’s keep this going!! The FPA financial house is in order and had a better than expected financial outlook. Many thanks to Treasurer Betty Harris, Pharm.D. for her stewardship of our finances. In order to better serve stakeholders within our organization, a number of ad-hoc committees were formed. To

address the needs and concerns of our compounding pharmacist members, a compounding practices sub-committee was created under the leadership of Mark Hobbs as Chair. The sub-committee on Rx Drug Abuse chaired by Lynn Lafferty was formed to address this growing problem in our state and throughout the country. Dr. Lafferty was an invited speaker at the prestigious Rx Drug Abuse Summit this year. DeAnne Mullins has agreed to chair the Academy of Independent Practitioners exploratory sub-committee. This will hopefully yield a first academy within the FPA to address the specific needs of our independent practitioners (owners, directors and managers). Finally, under the leadership of student pharmacist Ashley Rowand, the Student PAC Fundraising committee has begun its work. The committee is comprised of student members representing each college in the State. I think this committee is going to be a winner. I would like to thank all of the chairs and their teams for agreeing to do their very important work. I look forward to continuing to work with you in the years to come. I would like to thank Michael Jackson and the entire FPA staff for their dedication, hard work and support. Nothing could be accomplished without these folks. I wish incoming President Terry Gubbins, his Council Chairs, and all of the FPA leadership the best of luck this coming year. I look forward to being of service to them. I have spoken with Mr. Gubbins about the goals I set at the beginning of my term and the goals he plans to implement. I have encouraged him to continue to work toward the unification of our great profession. “One Message-One Voice.” Most importantly, I thank YOU, the members of the Florida Pharmacy Association. I am honored that you allowed me the privilege of serving you as your President. The future is here…. The revolution is underway… let us transform the practice of pharmacy!!! n Goar Alvarez, Pharm.D. President

JUNE 2013

Compounding Pharmacies Face Uncertainty with New Regulations By Jon Rawlson

A Florida pharmacist, frustrated with the federal government’s latest involvement in the drug compounding issue, posed this question at a recent meeting of the state Board of Pharmacy’s compounding committee: “Who’s in charge? The state or the FDA?” As the owner of a pharmacy that provides compounded pharmaceuticals, he added: “Does the Congress realize the turmoil that exists in the industry resulting from the FDA’s actions?” Pharmacy board members didn’t have any good answers. They and the rest of the nationwide industry hope new legislation that is making its way through Congress will provide clarity on regulations. This comes in the wake of the Massachusetts compounding disaster last fall that led to the deaths of more than 50 people nationwide from meningitis. At the heart of the issue is the same concern voiced by the Florida pharmacist: Who will be responsible for ensuring that compounded drugs are safe for the public? Regulation of compounding pharmacies typically has fallen to the boards of pharmacy in their respective states. Those boards are composed mostly of pharmacists appointed by the state’s governor, generally to four-year terms. Over the years, Congress has passed legislation designed to boost the Food and Drug Administration’s role in safeguarding the compounded product. This year’s legislation, however, could lead to a greater shift in the regulation of the compounding industry. As part of the FDA’s response to the meningitis outbreak, the agency teamed with a number of pharmacy boards across the country in unannounced inspections of more than 40 compound16

Flo r i d a P h a r m a c y To d a Y

ing pharmacies, targeting those who compound high-risk products in a sterile environment, as was the case in Massachusetts. In some cases, the investigations uncovered non-sterile pharmacy practices that ultimately led to drug recalls. According to the FDA, faulty medicine has been uncovered in a number of states, including Florida, Georgia and Tennessee. Currently under consideration is legislation proposed by Senate Health, Education, Labor and Pensions (HELP) Committee, which has jurisdiction over the FDA. Recently, the committee heard testimony and concerns from industry stakeholders on a proposed new classification and regulatory framework for pharmacy compounding. The new framework calls for federal oversight of pharmacies that meet three conditions: 1) compounding sterile drugs before receiving a prescription; 2) compounding sterile drugs without receiving a prescription; and 3) shipping the drug across state lines. Currently, the legislation exempts hospital pharmacies from the new compounding guidelines. Although the Senate committee heard from pharmacy associations and public health experts, it did not hear the unending questions and concerns from the industry over who will be in charge going forward, how the new regulations will be implemented, and how the proposed regulatory partnership between the federal and state governments will actually work. The Senate HELP legislation – S.959 - likely will be considered by the full Senate later this summer, possibly before the August recess. Although the House Energy and Commerce Health Subcommittee held hearings recently, it has yet to propose legislation. However, key Republican and Democrat Health Subcommittee Members

At the heart of the issue is the same concern voiced by the Florida pharmacist: Who will be responsible for ensuring that compounded drugs are safe for the public? are working on draft legislation that is expected to include some provisions found in the Senate bill. Depending on action in the House, the Senate bill could be considered by the full Senate as early this fall. At any rate, it is unlikely the final bill will pass Congress before the end of the year. A transition process is expected with “guidance” or additional guidelines for implementation from the FDA. The new regulatory framework could possibly be in place by the summer of 2014. Jon Rawlson is founder and president of Armory Hill Advocates, LLC, a boutique lobbying firm advocating for healthcare and nonprofit clients in Florida and Washington, D.C. For more information, visit http://armoryhilladvocates.com.

Buyer’s Guide florida PHARMACY TODAY

ADVERTISERS: This is a special section designed to give your company more exposure and to act as an easy reference for the pharmacist.

PHARMACY RESOURCES Abbott Diabetes Care Hernan Castellon (305) 220-0414 PPSC Retail Pharmacy Purchasing Program (888) 778-9909

LEGAL ASSISTANCE Kahan ◆ Heimberg, PLC Brian A. Kahan, R.Ph., Attorney at Law 561-392-9000 Fried Law Office, P.A. Dennis A. Fried, M.D., J.D. (407) 476-1427

PHARMACY CONSULTANTS HCC Pharmacy Business Solutions Bob Miller, BPharm, CPH (800) 642-1652 Empire Pharmacy Consultants Michael Chen PharmD., CPh President (786) 556-7825 Mobile (305) 374-1029 Office

TEMPORARY PHARMACISTs – STAFFING HealthCare Consultants Pharmacy Staffing Bob Miller (800) 642-1652

The Health Law Firm George F. Indest III, J.D., M.P.A., LL.M. (407) 331-6620

Empire Pharmacy Consultants Michael Chen PharmD., CPh President 855-374-1029

PHarmaceutical WHOLESALER

Rx Relief (800) RXRELIEF

McKesson Drug Company Jim Springer (800) 804-4590 FAX: (863) 616-2953

FREQUENTLY CALLED NUMBERS AHCA MEDICAID PHARMACY SERVICES 2727 Mahan Drive Tallahassee, FL 32308 (850) 412-4166 www.fdhc.state.fl.us/medicaid/ pharmacy AMERICAN PHARMACISTS ASSOCIATION (APhA) Washington, D.C. (800) 237-2742 www.pharmacist.com AMERICAN SOCIETY OF HEALTH SYSTEM PHARMACISTS Bethesda, MD (301) 657-3000 www.ashp.com/main.htm Drug Information Center Palm Beach Atlantic University (561) 803-2728 druginfocenter@pba.edu FLORIDA BOARD OF PHARMACY 4052 Bald Cypress Way Bin #C04 Tallahassee, FL 32399-3254 (850) 245-4292 www.doh.state.fl.us/mqa FLORIDA POISON INFORMATION CENTER NETWORK (800) 222-1222 www.fpicn.org National Community Pharmacists Association 100 Daingerfield Road Alexandria, VA 22314 703.683.8200 703.683.3619 fax info@ncpanet.org Recovering Pharmacists Network of Florida (407) 257-6606 “Pharmacists Helping Pharmacists”

Advertising in Florida Pharmacy Today Display Advertising: please call (850) 264-5111 for a media kit and rate sheet. Buyers’ Guide: A signed insertion of at least 3X per year, 1/3 page or larger display ad, earns a placement in the Buyers’ Guide. A screened ad is furnished at additional cost to the advertiser. Professional Referral Ads: FPA Members: $50 per 50 words; Non‑members: $100 per 50 words; No discounts for advertising agencies. All Professional Referral ads must be paid in advance, at the time of ad receipt.

JUNE 2013

Florida Pharmacy Association

123rd Annual Meeting and Convention July 10-14, 2013 â&#x20AC;˘ Orlando, Florida

Join the

EVOLUTION REVOLUTION Transform the Profession of Pharmacy

FPA 123rd Annual Meeting and Convention Schedule JW Marriott Grande Lakes 4040 Central Florida Parkway Orlando, FL 32837 (800) 266-9432 18

Flo r i d a P h a r m a c y To d a Y

FPA 123rd Annual Meeting and Convention Schedule July 10-14, 2013

Schedule is subject to change.

Wednesday, July 10, 2013 6 hrs GCE/TECH/RC

7:00am

Registration Desk Opens

7:45am

Welcome and Introductory Remarks

8:00am-3:30pm Education: 6 hrs GCE/TECH/RC Pharmaceutical Compounding Program 8:00am-9:00am Education: 1 hr GCE/TECH/RC Compounding Pharmacy Today, Where Are We? Sam Pratt, BPharm, FIACP-Pharmacy Specialists Upon completion of this activity, pharmacists will be able to: Define pharmacy compounding; Outline the historical development of pharmacy regulation; Identify pivotal court decisions that have shaped the regulation of pharmacy compounding; Discuss pharmacy compounding in the Florida statutes; Illustrate the role FDA plays in regulating compounding pharmacies; Discuss the NECC tragedy and its ramifications on compounding; Examine the role professional organizations play in maintaining the integrity and quality of compounding. UAN: 0165-0000-13-028-L04-P* Upon completion of this activity, technicians will be able to: Define pharmacy compounding; Recognize the Florida statutes regarding pharmacy compounding; Identify the role of the FDA in regulating compounding pharmacies. UAN: 0165-0000-13-028-L04-T* 9:05am-10:05am Education: 1 hr GCE/TECH/RC Compounding Pharmacy Laws and Rules Ed Bayo, Attorney, Grossman, Furlow & Bayo, LLC Upon completion of this activity, pharmacists will be able to: Discuss pharmacy laws and rules governing compounding; Describe the role of the Florida Board of Pharmacy; Identify current enforcement trends pertaining to pharmacy compounding. UAN: 0165-0000-13-029-L04-P* Upon completion of this activity, technicians will be able to: Identify the various rules and laws pertaining compounding; List the duties of a pharmacy technician in compounding; Recognize the newest trend in pharmacy compounding. UAN: 0165-0000-13-029-L04-T* 10:05am-10:20am

Break

10:20am-11:20am Education: 1 hr GCE/TECH/RC Quality Assurance in Compounding David Joseph, BPharm, Anazao Health Corp, Director, Pharmacy, Regulatory Compliance and Quality Upon completion of this activity, pharmacists will be able to: Describe the historical evolution of compounding; Summarize significant occurrences which have called attention to the need for QA in compounding; Describe the industry and regulatory changes which 2

CODE KEY:

GCE = General Continuing Education

have lead to today’s compounded processes; Discuss how to put into practice compounding QA based on 4 basis tenants: Policy and Procedure, Training, Facility, CQI. UAN: 0165-0000-13-030-L04-P* Upon completion of this activity, technicians will be able to: Define quality assurance in compounding; Recognize the history of compounding; Identify the recent events which have affected pharmacy compounding and learn how to avoid these events. UAN: 0165-0000-13-030-L04-T* 11:25am-12:25pm Education: 1 hr GCE/TECH/RC Pharmaceutical Compounding for Clinical Trials Prince Hinson, BPharm – Westlab Pharmacy Upon completion of this activity, pharmacists and technicians will be able to: Define Compounding in Pharmacy Practice; Discuss clinical trial classifications; Identify opportunities for compounding in clinical trials; Describe examples of compounding in previous clinical trials. UAN: 0165-0000-13-031-L04-P* Upon completion of this activity, technicians will be able to: Define clinical trials; List the different clinical trial classifications; Recognize the importance of compounding in clinical trials. UAN: 0165-0000-13-031-L04-T* 12:25pm-1:10pm

Lunch

1:15pm-2:15pm Education: 1 hr GCE/TECH/RC Florida Board of Pharmacy Compounding Inspections Jeane Clyne, Chief, Investigative Services Unit, Division of MQA Upon completion of this activity, pharmacists will be able to: Identify risk level for compounding of sterile products; Discuss what documentation is required during a compounding inspection; Describe knowledge of requirements based on risk level to include training and testing. UAN: 0165-0000-13-032-L04-P* Upon completion of this activity, technicians will be able to: Define sterile products; Recognize the documentation that is required during a compounding inspection; Identify roles pharmacy technicians can perform during compounding inspections. UAN: 0165-0000-13-032-L04-T* 2:20pm-3:20pm Education: 1 hr GCE/TECH/RC Sports Medicine and Pain Management Bob Hoye, BPharm, FIACP, FACA President, Hoye’s Pharmacy Upon completion of this activity, pharmacists will be able to: Describe the physiology of pain with an emphasis on transmission at the receptor level; Explain the mechanisms of abnormal pain and the plastic changes that occur in chronic pain; Summarize the mechanisms of action of the medications prescribed to treat pain; Identify topical options for pain and analyze evidence to support their use. UAN: 0165-0000-13-033-L04-P* Upon completion of this activity, technicians will be able to: Recognize the origin of pain; List pain receptors; Identify topical medications used for pain. UAN: 0165-0000-13-033-L04-T*

RC = Recertification Consultant

TECH = Technician

STC = Student Continuing Education JUNE 2013

4:00pm-5:00pm

HOD Board of Directors Meeting

5:00pm-6:00pm

Florida Pharmacy PACCE Meeting

6:00pm-7:00pm

Budget & Finance Committee Meeting

7:30pm-9:00pm

Florida Pharmacy Association Officer’s Meeting

7:30pm

Florida Pharmacy Foundation Annual Meeting

Thursday, July 11, 2013 6 hrs GCE or 3 hrs RC

7:00am

Registration Desk Opens

7:45am-9:15am Education: 1.5 hrs GCE/TECH/RC Bariatric Surgery Patients: What Every Pharmacist Needs To Know About This Growing Population Carol Motycka, PharmD, BCACP, Associate Professor and Assistant Dean, University of Florida Upon completion of this activity, pharmacists will be able to: Discuss the difference between gastric bypass and banding procedures and their effects on pharmacokinetics; Recognize how each procedure impacts a patient’s nutritional needs; Explain the effect each procedure has on a patient’s current medication therapies as well as future implications on medication therapy. UAN: 0165-0000-13-034-L04-P* Upon completion of this activity, technicians will be able to: Recognize the difference between gastric bypass and banding procedures; List nutritional needs that are affected from bariatric procedures; Identify the possible consequences of a patient who lacks nutritional needs due to bariatric procedures. UAN: 0165-0000-13-034-L04-T* 8:00am-10:00am

Delegate Registration

9:00am-10:30am Non CE Program CE Provider Workshop for Florida Department of Health Providers Carl “Fritz” Hayes, RPh, Past Member-Florida Board of Pharmacy; Past Chair-Tripartite Committee Marcia Mann, CE Broker Representative Garnet Nevels, Government Operations Consultant II, Bureau of Operations, Florida Department of Health Upon completion of this activity, participants will be able to: Identify and understand Florida rules and regulatory updates regarding: Continuing education requirements for Florida licensed Pharmacists; Continuing education requirements for Florida registered Technicians; Responsibilities for approved provider program administrators; Record keeping requirements and audit information for providers; CPE Monitor requirements for all pharmacists and technicians. 9:20am-10:50am Education: 1.5 hrs GCE/TECH/RC Herbal Supplements in Complementary and Integrative Medicine: The Good, The Bad, The Uneventful Michael Schuh, BS, PharmD, MBA, Assistant Professor of Family and Consultant Track 20

Flo r i d a P h a r m a c y To d a Y

Palliative Medicine, Assistant Professor of Pharmacy, Mayo Clinic College of Medicine, Clinical Assistant Professor, University of Florida Upon completion of this activity, pharmacists will be able to: Summarize the history and background of herbal supplements; Contrast the difference in herbals with prescription (Rx) medications and over-the counter (OTC) medications; Describe quality issues; Describe the popularity of herbal supplements in the United States; Analyze common herbal and nutritional supplement properties and uses; Review possible drug interactions with RX and OTC medications through case studies; Discuss clinical applications of herbal medications. UAN: 0165-0000-13-035-L04-P* Upon completion of this activity, technicians will be able to: Define herbal supplements; Recognize the difference between herbal supplements and prescriptions; Recognize the difference between herbal supplements and OTC medications. UAN: 0165-0000-13-035-L04-T* 10:55am-11:55am Education: 1 hr GCE/TECH Navigating Opportunities in Mobile Health with Your Patients Kevin A, Clauson, PharmD, Director, Center for Consumer Health Informatics Research and Associate Professor, Nova Southeastern University, College of Pharmacy Upon completion of this activity, pharmacists will be able to: Outline currently available patient-centric mobile health (mHealth) applications (apps); Discuss the use of mHealth tools to enhance patient self-care and improve medication adherence; Delineate approaches of how to guide patients to mHealth apps and tools; Articulate pitfalls associated with use of mobile apps and devices. UAN: 0165-0000-13-036-L04-P* Upon completion of this activity, technicians will be able to: Recognize currently available patient-centric mobile health (mHealth) apps; List approaches of how to guide patients to mHealth apps and tools; Identify pitfalls associated with use of mobile apps and devices. UAN: 0165-0000-13-036-L04-T* 11:00am-1:00pm

FPA House of Delegates and Annual Business Meeting

12:00pm-1:00pm

Lunch (Attendees on their own)

12:00pm-1:00pm

Independent Pharmacist Luncheon (Invitation Only)

12:00pm-1:00pm

Merck Luncheon (RSVP by June 14 as seating is limited)

1:00pm-2:00pm Education: 1 hr GCE/TECH Transforming the Practice of Pharmacy: The Beers List and Nonprescription Drugs Richard Finkel, PharmD, Clinical Assistant Professor, Nova Southeastern University College of Pharmacy Upon completion of this activity, pharmacists will be able to: Create a plan to discuss prescription, nonprescription medications and lifestyle issues that may be inappropriate for the elderly patient; Develop a strategy with the patient or caregiver to be alert to potential nonprescription (OTC) medications that would possibly decrease therapeutic outcomes or increase adverse effects when combined with prescription medications; Design a patient-specific document for the patient or caregiver to take home for reference, using words that have meaning for the reader; Build a “bridge” between the person and the pharmacist so that the best 3

patient outcomes can be realized; Set up a call-back system for phone or computer communication for reviewing the information at appropriate intervals; Arrange collaboration with other members of the patient’s health team to proactively create open communication to achieve the best patient outcomes. UAN: 0165-0000-13-037-L04-P** Upon completion of this activity, technicians will be able to: Define Beers list; Recognize medications on the Beers list which should be avoided in the elderly; Identify lifestyle issues that may be inappropriate for the elderly. UAN: 0165-0000-13-037-L04-T** 2:05pm-3:05pm Education: 1 hr GCE/TECH/STC Keynote Address: “Transform Healthcare in 2013: A Call-to-Action for Pharmacy” Rear Admiral Scott F. Giberson, RPh, PhC, NCPS-PP, MPH, Hon. Sc.D., U.S. Assistant Surgeon General, Director, Commissioned Corps Personnel and Readiness; Chief Professional Officer, Pharmacy Upon completion of this activity, pharmacists will be able to: Discuss Pharmacy Report to the U.S. Surgeon General; Develop transformative thinking based on current health system needs and pharmacy practice; Facilitate partnerships at the state level to help transform the profession; Inspire a call-to-action that will improve the Nation’s health. UAN: 0165-0000-13-038-L04-P* Upon completion of this activity, technicians will be able to: Recognize the role of the U.S. Surgeon General; Identify ways to develop transformative thinking based on current health system needs; Recognize the role of state partnerships and how it can help improve the profession. UAN: 0165-0000-13-038-L04-T* 3:05pm-5:05pm

House of Delegates Reconvenes

6:00pm-7:00pm

Adopt-A-Student and Mentor Social

Friday, July 12, 2013 6 hrs GCE/TECH/RC

7:00am

Registration Desk Opens

7:00am-8:00am

Christian Pharmacist Fellowship International Breakfast

7:45am-9:15am Education: 1.5 hrs GCE/TECH/RC Use of Drugs During Pregnancy and Lactation Fallon Enfinger, PharmD, CDE, Assistant Professor of Pharmacy Practice, LECOM School of Pharmacy Upon completion of this activity, pharmacists will be able to: Define and interpret the FDA categories for the use of medications during pregnancy; Explain pharmacokinetic changes during pregnancy; Explain the general principles of drug transfer across the placenta and into breast milk; Discuss considerations of drug selection in pregnancy; Explain the need for folic acid supplementation in pregnancy; Identify common acute and chronic conditions associated with pregnancy and the appropriate treatment options available; Identify specified teratogens, drugs with nonteratogenic adverse effects, and safe drugs for use during pregnancy and breastfeeding; Counsel pregnant and breastfeeding patients on appropriate medication use; Aid patients and providers in selecting 4

CODE KEY:

GCE = General Continuing Education

the appropriate pharmacotherapy for pregnant and breastfeeding patients while weighing the risk versus benefit. UAN: 0165-0000-13-039-L01-P** Upon completion of this activity, technicians will be able to: List the categories for medications used during pregnancy; Recognize the need for folic acid supplementation in pregnancy; Identify common conditions associated with pregnancy. UAN: 0165-0000-13-039-L01-T** 9:00am-10:30am Education: 1.5 hrs GCE/TECH/STC NASPA/NMA Game Show Tian Merren Owens, MS, PharmD, Director of Continuing Education, Florida Pharmacy Association Upon completion of this activity, pharmacists will be able to: Identify and explain aspects of the effective and safe practice of pharmacy self care treatments through a process of answering a selected group of questions similar to a national board exam; Analyze the usage and effectiveness of over-the-counter medications; Classify different groups of over-the-counter medications based on drug treatment classes. UAN: 0165-0000-13-040-L04-P* Upon completion of this activity, technicians will be able to: Identify the use of over-the-counter medications; List the classes of various OTC products; Identify proper storage and handling techniques of OTC products. UAN: 0165-0000-13-040-L04-T* 9:00am-11:00am

Journal Board Meeting

9:20am-10:50am Education: 1.5 hrs GCE/TECH/RC No Bones About It – Osteoporosis Update Katherine Heller, PharmD, Vice President Clinical Solutions– Integrated Delivery Systems & Patient Services, Walgreens Upon completion of this activity, pharmacists will be able to: Define osteoporosis; Describe the pathophysiology of osteoporosis; Recognize and manage risk factors for the development of osteoporosis; Identify gender-specific differences in bone development as well as osteoporosis etiology, prevention and treatment options; Identify and explain appropriate prevention and treatment options; Describe potential roles of the pharmacist in osteoporosis prevention and management. UAN: 0165-0000-13-041-L01-P** Upon completion of this activity, technicians will be able to: Define osteoporosis; Identify risk factors for osteoporosis; List medications used to treat osteoporosis. UAN: 0165-0000-13-041-L01-T** 11:00am-1:00pm

Exhibit Hall Grand Opening

11:00am-1:00pm

Student Poster Presentations

12:00pm-1:00pm

Lunch (Attendees on their own)

12:30pm-2:30pm

Local Unit Leaders Meeting

1:00pm-2:30pm Education: 1.5 hrs GCE/TECH/STC Transforming Pharmacy Practice through Motivational Interviewing Heather MW Petrelli, MA, Assistant Dean, Instructor, Department of Pharmacotherapeutics and Clinical Research, USF College of Pharmacy Erini Serag-Bolos, PharmD, Assistant Professor, Pharmacy Practice, USF College of Pharmacy

RC = Recertification Consultant

TECH = Technician

STC = Student Continuing Education JUNE 2013

Upon completion of this activity, pharmacists will be able to: Identify historical and theoretical foundations of motivational interviewing (MI) in healthcare and pharmacy practice; Describe outcomes of MI as presented in the literature; Increase understanding of the basic skills of MI; Identify strategies for inclusion of MI in pharmacy practice; Identify current practice models that have successfully implemented MI strategies; Explain strategies for training and role-playing in MI; Demonstrate basic MI skills through role-playing. UAN: 0165-0000-13-042-L04-P* Upon completion of this activity, technicians will be able to: Define motivational interviewing (MI); Recognize the history of MI in pharmacy; List the basic skills of MI. UAN: 0165-0000-13-042-L04-T* 1:00pm-3:00pm Education: 2 hrs GCE/TECH/RC A Review and Update on Men’s Health Issues: A Focus on Benign Prostatic Hyperplasia and Erectile Dysfunction Dana A. Brown, PharmD, BCPS, Assistant Dean for Academics, Associate Professor, Palm Beach Atlantic University, Lloyd L. Gregory School of Pharmacy Upon completion of this activity, pharmacists will be able to: Explain the pathophysiology of benign prostatic hyperplasia (BPH) and erectile dysfunction (ED), including factors which can worsen BPH and risk factors/causes of ED; Recognize the clinical presentation of BPH and ED, including common signs and symptoms; Provide appropriate non-pharmacologic and pharmacologic recommendations for a given patient with BPH and/ or ED based on patient-specific parameters; Counsel a given patient on the appropriate administration and potential adverse effects of various BPH and/or ED treatment modalities; Compare and contrast BPH and ED treatment modalities with regards to adverse effects, role in therapy, and drug-drug interaction considerations; Discuss the role of complementary alternative medicine (CAM) therapies in the management of BPH; Explain patient characteristics that would make various ED and BPH treatment modalities inappropriate (i.e. contraindications). UAN: 0165-0000-13-043-L01-P** Upon completion of this activity, technicians will be able to: Define BPH and ED; List factors that can worsen BPH and ED; Identify signs and symptoms of BPH and ED. UAN: 0165-0000-13-043-L01-T** 1:15pm-4:15pm

Student Patient Counseling Competition

1:30pm-2:00pm

Golf Tournament Practice

2:00pm

PACCE Golf Tournament

2:35pm-4:05pm Education: 1.5 hrs GCE/TECH/STC Preparing Yourself for a Pharmacy Career-A Focus on Interviewing Skills and Resume Development Jennifer Pytlarz, PharmD, BCACP, Assistant Professor, Department of Pharmacotherapeutics & Clinical Research, University of South Florida, College of Pharmacy Upon completion of this activity, pharmacists will be able to: Describe different job search strategies; Explain the difference between a resume and CV; Provide tips on how to build a resume and CV; Discuss how to prepare for an interview; Review the interview process including questions to ask and questions to be prepared to answer. UAN: 0165-0000-13-045-L04-P* Upon completion of this activity, students and technicians will be able to: Describe different job search strategies; Explain the difference between a resume and CV; Provide tips on how to build a resume and CV; Discuss how to prepare for an interview; Review the interview Consultant Track 22

Flo r i d a P h a r m a c y To d a Y

process including questions to ask and questions to be prepared to answer. UAN: 0165-0000-13-045-L04-T* 3:05pm-4:05pm Education: 1 hr GCE/TECH/RC Avoiding the ‘Oops!’: An Earnest Discussion of Contraception Fallon Enfinger, PharmD, CDE, Assistant Professor of Pharmacy Practice, LECOM School of Pharmacy Upon completion of this activity, pharmacists will be able to: Explain the hormone regulation of the menstrual cycle; Discuss failure rates for each method of contraception; Differentiate between the available hormonal contraceptives (monophasic, biphasic, triphasic; extended cycle, continuous, minipills; alternatives; etc.); Identify signs and symptoms of serious adverse events of hormonal contraceptives that warrant immediate discontinuation; Counsel a patient on the use of each contraceptive option; Aid patients and providers in choosing the appropriate contraception based on patient-specific considerations; Recommend contraception modifications when necessary; Properly advise a patient that has missed a dose or doses of an oral contraceptive agent; Discuss emergency contraception, its mechanism, and controversy related to its dispensing; Counsel a patient on the use of emergency contraception. UAN: 0165-0000-13-044-L01-P** Upon completion of this activity, technicians will be able to: List the hormones associated with the menstrual cycle; Identify contraception methods which have a high success rate; Recognize signs and symptoms of serious side effects that may warrant discontinuation. UAN: 0165-0000-13-044-L01-T** 5:00pm-6:30pm

PACCE Reception

7:00pm-8:30pm

University Alumni Receptions

8:00pm-11:00pm

Florida Pharmacy Foundation “CASINO NIGHT”

Saturday, July 13, 2013

6 hrs RC or 7 hrs GCE/TECH 6:30am ZUMBA at FPA! Jenni Harris, PharmD, Publix Super Markets, Inc., Licensed ZUMBA Instructor Are you ready to party yourself into shape? That’s exactly what the Zumba® program is all about. It’s an exhilarating, effective, easy-tofollow, Latin-inspired, calorie-burning dance fitness-party that’s moving millions of people toward joy and health. 7:00am

Registration Desk Opens

7:45am-8:45am Education: 1 hr GCE/TECH/RC MTM Practice Models and CPT Coding Update Daniel E. Buffington, PharmD, MBA, Clinical – Forensic Pharmacologist, Clinical Pharmacology Services, Inc Upon completion of this activity, pharmacists will be able to: Identify pharmacist services practice models; Summarize pharmacist services and established MTM CPT codes; Differentiate MTM in the health care market vs. Medicare Part-D; Distinguish different types of healthcare coding models: CPT, ICD and Quality Measures; Identify national initiatives to enhance payer acceptance for MTM. UAN: 0165-0000-13-056-L04-P* 5

Upon completion of this activity, technicians will be able to: Define MTM; Recognize the difference between MTM and Medicare Part-D health care; List the different types of healthcare coding models. UAN: 0165-0000-13-056-L04-T* 7:45am-9:15am Education 1.5 hrs GCE/TECH Pharmacy Business Plan Basics Jim Springer, Regional Vice President, Rx Ownership, McKesson Corp. Upon completion of this activity, pharmacists will be able to: Explain why you need a business plan; Identify the most important first step in setting your course for long term success of your drug store; List the key components of a business plan; Identify resources that can help produce the business plan. UAN: 0165-0000-13-046-L04-P* Upon completion of this activity, technicians will be able to: Recognize the importance of a business plan; List the first step in beginning a successful business; List key components of a business plan. UAN: 0165-0000-13-046-L04T* 8:50am-9:50am Education: 1 hr GCE/TECH/RC Future Health Care Models and MTM Opportunities Jeff Vaughan, PharmD, MS, Clinical – Forensic Pharmacologist, Clinical Pharmacology Services, Inc. Upon completion of this activity, pharmacists will be able to: Outline future healthcare reform-based practice models; Discuss emerging payment opportunities for pharmacists, including: Payfor-Performance models (P4P), Patient-centered medical homes (PCMH), and Accountable Care Organizations (ACO); Describe opportunities for collaboration and networking to enhance public and payer awareness of Pharmacist’s services (MTM); Evaluate the rate of development of health care reform models in the US health care system. UAN: 0165-0000-13-057-L04-P* Upon completion of this activity, technicians will be able to: Define Pay-4-Performance models; Define Patient-centered medical homes; Identify the role of a technician in future MTM healthcare. UAN: 0165-0000-13-057-L04-T* 9:00am-11:00am Education: 2 hrs STC (Non CE) Pharmacy Career Forum: Academia, Compounding, Consultant, Hospital & Independent Pharmacy Practice Settings Theresa Tolle, BPharm, FAPhA, Owner, Bay Street Pharmacy, Inc. Upon completion of this activity, pharmacists and technicians will be able to: Recognize various practices of pharmacy and opportunities available to pharmacists and technicians; Describe the practice setting that best suit the individual skills and abilities; Identify personal strengths and weaknesses to consider when contemplating career choices. 9:20am-10:50am Education 1.5 hrs GCE/TECH My Profits Have Fallen and I Can’t Get Up Clarence W. Lea, RPh, Vice President, Marketing & Industry Relations, Lagniappe Pharmacy Services Upon completion of this activity, pharmacists will be able to: List at least three factors in pharmacy profitability; Recognize the impact of expenses on pharmacy profitability; Identify how reports can be useful in measuring profits and finding new profit opportunities; List at least 3 types of pharmacy related programs/services that can improve their profits; Discuss how marketing their pharmacy can improve profitability. UAN: 0165-0000-13-047-L04-P* Upon completion of this activity, technicians will be able to: Recognize 6

CODE KEY:

GCE = General Continuing Education

hidden areas of revenue opportunities in the pharmacy; Identify areas in pharmacy that produce profit loss; List ways social media can be used to increase income. UAN: 0165-0000-13-047-L04-T* 9:55am-10:55am Education: 1 hr GCE/TECH/RC Medication Therapy Management: Coding Case Studies Sean Casella, PharmD, Resident, Clinical Pharmacology Services, Inc. Upon completion of this activity, pharmacists will be able to: Identify pharmacists services (MTM) opportunities in diverse practice settings; Discuss pre and post MTM service phases related to the patient and payer; Describe the service documentation criteria essential to submitting for MTM reimbursement; Present practical Medication Therapy Management (MTM) case scenarios. UAN: 0165-0000-13-058-L04-P* Upon completion of this activity, technicians will be able to: Recognize the different MTM services available; List the items required for MTM reimbursement; Recognize the role pharmacy technicians can play in submitting documents for reimbursements. UAN: 0165-0000-13-058-L04-T* 11:00am-1:00pm

Exhibit Hall Opens

12:00pm

Golf Winners Announced in Exhibit Hall

12:00pm-1:00pm

Lunch (Attendees on their own)

1:00pm-2:30pm

Student Luncheon

1:00pm-2:30pm Education: 1.5 hrs GCE/TECH/RC Integrative and Alternative Medicine in Pharmacy Practice - Part I Lynn Lafferty, PharmD, ND, CNC, Coordinator of the Integrative Alternative and Complementary Medicine Program, Nova Southeastern College of Osteopathic Medicine Upon completion of this activity, pharmacists will be able to: Discuss stomach and gut physiology and biochemistry; Identify ways to supplement with whole food supplements and herbs to balance stomach and bowel conditions; Comprehend the complex physiology and biochemistry of the endocrine system and how to balance it using herbs and whole food; Review the pharmacologic principles of whole foods, diet and herbs. UAN: 0165-0000-13-048-L01-P* Upon completion of this activity, technicians will be able to: Define integrative and alternative; Recognize the role of the stomach and gut in alternative medicine; List the whole foods and herbs that are used to balance stomach and bowel conditions. UAN:0165-0000-13-048-L01-T* 1:00pm-2:30pm Education: 1.5 hrs GCE/TECH Overview of Pharmacy Audits – Types, Expectation, Preparation, Prevention Isaac Butler, PharmD, MBA, Director, Network Pharmacy Audit, Express Scripts, Inc. Steven McCall, RPh, MBA, Director, Pharmacy Performance, CVS/Caremark Anne Sayther, Director, Pharmacy Audit, Prime Therapeutics Upon completion of this activity, pharmacists will be able to: Describe the best practices to be prepared for audits of retail pharmacies; Recognize the different types of audits and their objectives; Identify government regulations and training methods to have your pharmacy team be prepared. UAN: 0165-0000-13-049-L04-P* Upon completion of this activity, technicians will be able to: Define

RC = Recertification Consultant

TECH = Technician

STC = Student Continuing Education JUNE 2013

pharmacy audits; List the different types of audits; Recognize how technicians can assist in the preparation of audits. UAN: 0165-0000-13-049-L04-T* 2:35pm-4:05pm Education: 1.5 hrs GCE/TECH/RC Integrative and Alternative Medicine in Pharmacy Practice - Part 2 Lynn Lafferty, PharmD, ND, CNC, Coordinator of the Integrative Alternative and Complementary Medicine Program, Nova Southeastern College of Osteopathic Medicine Upon completion of this activity, pharmacists will be able to: Discuss stomach and gut physiology and biochemistry; Identify ways to supplement with whole food supplements and herbs to balance stomach and bowel conditions; Comprehend the complex physiology and biochemistry of the endocrine system and how to balance it using herbs and whole food; Review the pharmacologic principles of whole foods, diet and herbs. UAN: 0165-0000-13-050-L01-P* Upon completion of this activity, technicians will be able to: Define integrative and alternative; Recognize the role of the stomach and gut in alternative medicine; List the whole foods and herbs that are used to balance stomach and bowel conditions. UAN: 0165-0000-13-050-L01-T* 2:35pm-5:05pm Education: 2.5 hrs GCE/TECH Pharmacy Economics/Financial Skills 101 Alvey Squires, Cardinal Health VP (Retired) Upon completion of this activity, pharmacists will be able to: Identify basic financial skills that will make you a more effective business manager; Assess financial performance by identifying strengths, weaknesses and areas of opportunity; Discuss cash flow and the pain points behind unsatisfactory pharmacy performances; Use financials to monitor profitability. UAN: 0165-0000-13-051-L04-P* Upon completion of this activity, technicians will be able to: Recognize the basic financial skills necessary for a business manager; Define SWOT; Identify the importance of cash flow and the negative effects of a pharmacy’s performance. UAN: 0165-0000-13-051-L04-T* 2:35pm-4:05pm

Pharmacy Student Summit

5:00pm-6:30pm

Past Presidents Reception (Invitation Only)

7:00pm-10:00pm

Awards Ceremony Reception Theme: “Mardi Gras” Attire: Beads, Masks, Gold, Green, and Purple Colors

Sunday, July 14, 2013 5 hrs GCE/TECH

7:00am

Registration Desk Opens

7:00am-8:30am

President’s Breakfast and Installation of Officers

7:30am-8:30am Education: 1 hr GCE/TECH Optimizing Patient Care with Medication Reconciliation, Medication Therapy Management, and Transition of Care Zipporah-Darvi Redding, AS, RPhT, CPhT, MTM/Patient Scheduler, Family Physicians Group; Adherence Pharmacy Technician, University of Florida, College of Pharmacy, Department of Pharmacotherapy & Translational Research MTM Communication and Care Centers -Lake Nona Consultant Track 24

Upon completion of this activity, pharmacists will be able to: Describe the pharmacist role in providing quality care and services utilizing Medication Reconciliation, MTM, and Transition of Care; Explain Beers list and its affects in geriatric patients; Discuss poly-pharmacy focusing on patient safety; Demonstrate motivational interviewing. UAN: 0165-0000-13-052-L04-P* Upon completion of this activity, technicians will be able to: Define Medication Reconciliation, MTM, and Transition of Care; Review Beers list and its affects in geriatric patients; Recognize advantages in expanded technician roles to assist pharmacists optimizing patient care; Distinguish between judgmental and non-judgmental tasks in the pharmacy; List methods to promote medication adherence. UAN: 0165-0000-13-052-L04-T* 8:35am-10:35am Education:2 hrs GCE/TECH Reducing Medication Errors through Implementing a Continuous Quality Improvement Program Michael Jackson, BPharm, CPh, Executive Vice President and CEO, Florida Pharmacy Association Upon completion of this activity, pharmacists should be able to: Define elements of a Continuous Quality Improvement (CQI) Program; Restructure a pharmacy practice to address quality related events; Analyze some common causes of quality related events; Implement an action plan to address quality of care in pharmacies with a goal towards error reduction and prevention; Recite quality improvement regulations for Florida pharmacies. UAN: 0165-0000-13-053-L05-P* Upon completion of this activity, technicians should be able to: Define CQI; List most common medication errors; Employ techniques to reduce medication errors by using CQI. UAN: 0165-0000-13-053-L05-T* 10:35am-10:50am Break 10:50am-11:50am Education: 1 hr GCE/TECH HIV/AIDS Update Sami Shafiq, PharmD, CPh, AAHIVE, Lead HIV/AIDS Clinical Pharmacist, Miami Market, Clinical Assistant Professor of Pharmacy Practice, NOVA Southeastern University/Palm Beach Atlantic University Upon completion of this activity, pharmacists will be able to: Review current modes of transmission; Identify high risk behaviors; Discuss the pharmacist role in providing care for HIV infected patients; Describe the mechanism of actions of antivirals; Describe the rationale behind combination therapies; Interpret current Florida law on HIV/AIDS. UAN: 0165-0000-13-054-L02-P* Upon completion technicians will be able to: Define HIV and AIDS; List methods of transmission of HIV/AIDS; Identify high risk behaviors. UAN: 0165-0000-13-054-L02-T* 11:55am-12:55pm Education: 1 hr GCE/TECH Legislative and Regulatory Update Michael Jackson, BPharm, CPh, Executive Vice President and CEO, Florida Pharmacy Association Upon completion of this activity, pharmacists will be able to: Recite recent changes in pharmacy laws which affect the practice of pharmacy in Florida; Describe issues of state and national interest to the profession of pharmacy; Identify recent statutory changes that affect the role of pharmacy technicians. UAN: 0165-0000-13-055-L03-P* Upon completion of this activity, technicians will be able to: Identify recent changes in pharmacy laws which affect the practice of pharmacy in Florida; Describe issues of state and national interest to the profession of pharmacy; Recognize recent statutory changes that affect the role of pharmacy technicians. UAN: 0165-0000-13-055-L03-T* 7

Flo r i d a P h a r m a c y To d a Y

2013 Attendee brochure.indd 7

3/15/2013 9:55:41 AM

General Information Room Rates

$149 single/double occupancy for standard deluxe room. The room reservation deadline is Monday, June 17, 2013 or when room block is full. Thereafter, reservations may be taken on a space available or rate available basis. Please be sure to ask for the Florida Pharmacy Association group rate. The check-in time is 3:00pm and the checkout time is 11:00 am. Room reservations can be made by calling (800) 266-9432. Guest self parking is $9 per day. Valet parking is $24 per day.

Keynote Speaker Rear Admiral Scott F. Giberson U.S. Assistant Surgeon General Director, Commissioned Corps Personnel and Readiness Chief Professional Officer, Pharmacy RADM Scott Giberson was selected by U.S. Surgeon General Regina Benjamin as the first Director of the Division of Commissioned Corps Personnel and Readiness (CCPR) in August 2011. He has operational leadership for a new Commissioned Corps infrastructure that provides the management of all personnel and readiness systems for over 6,500 Commissioned Corps officers. In addition to his full-time responsibilities as the Director of CCPR, RADM Giberson was also selected by Dr. Benjamin for a four-year term as the Chief Professional Officer (CPO) for the Pharmacy Category of the U.S. Public Health Service (PHS), effective March 16, 2010. As the CPO, he advises the Office of the Surgeon General and the Department of Health and Human Services on operational and professional affairs of over 1,150 PHS pharmacists. RADM Giberson has served in roles as a Clinical Pharmacist, Chief Pharmacist, Senior Public Health Advisor, Senior Medical Program Officer, Acting Division Director, and Principal Consultant. RADM Giberson began his career in Gallup, New Mexico as a clinical pharmacist in the Indian Health Service (IHS) in 1994. In the mid-90s, he implemented pharmacy-based disease management clinics for hypertension and hyperlipidemia in Tohatchi, New Mexico. He increased his clinical expertise through two unique programs to expand his scope of practice. RADM Giberson was one of the first pharmacists in the PHS to ever become licensed as a Pharmacist Clinician and certified as an IHS Pharmacy Practitioner. He also was one of the founding members of the National Clinical Pharmacy Specialist (NCPS) Program in 1997. Today, the NCPS Program continues to thrive and has recognized over 225 8

pharmacists — in the IHS and now expanded to the Bureau of Prisons. In 1998, he (and a small group of IHS pharmacists) became the first federal pharmacists to be compensated by a state Medicaid program as non-physician practitioners. RADM Giberson then became a long-standing member (privileged by physicians) of the Family Practice medical staff in Gallup, NM. He still holds those privileges today after 13 years. In 2000, RADM Giberson became the Chief Pharmacist at the Fond du Lac (FDL) Health Clinic in Cloquet, Minnesota where he continued as a non-physician primary care provider. RADM Giberson has taught hundreds of students at the IHS Clinical Pharmacy Practice Training Program (PPTP) and has lectured at many pharmacy schools across the U.S. In 2001, RADM Giberson responded to the Anthrax attacks and provided care to postal workers in New York City. He was later chosen by his peers as the National Coordinator for over 40 Nurse and Pharmacist Response Teams as he worked under the newly-formed Department of Homeland Security. In 2003, RADM Giberson was detailed to the Department of Defense for three years. He served on many international health missions for the U.S. Pacific Command involving more than 23 countries. His bilateral work with specific countries also included Thailand, India, Vietnam, Papua New Guinea, and Australia. He traveled extensively working with foreign militaries on HIV/AIDS and other initiatives. Following his work in the Pacific, he transitioned back to the IHS as their National HIV/AIDS Program Principal Consultant. He greatly expanded the program and became a sought-after consultant on HIV/AIDS programs. He also served as a Steering Committee member for President Obama’s National HIV/AIDS Strategy. RADM Giberson has advocated across his career to advance the pharmacy profession. He maintains dual licensure as a pharmacist and clinician, and has worked as a member of an IHS Family Practice Medical staff for most of his career. He is the primary author of Improving Patient and Health System Outcomes through Advanced Pharmacy Practice – A Report to the U.S. Surgeon General 2011 that garnered the U.S. Surgeon General’s public support. RADM Giberson also co-authored and facilitated the development of the first Federal Pharmacist Vision and Scope of Practice with the Federal Pharmacy Chiefs from the Department of Defense and the Department of Veterans Affairs. RADM Giberson has experience as a global health consultant to the U.S. Marine Corps Command Staff and College during their Capstone exercise. He has received numerous PHS awards across his career, including the Clinical Pharmacist of the Year and a Department of Defense Meritorious Service Medal for his global health work. RADM Giberson holds a Bachelor’s Degree in Pharmacy from Temple University, a Master’s Degree in Public Health from the University of Massachusetts, and a graduate certificate in Health Emergencies in Large Populations, a graduate-level program developed by the International Committee of the Red Cross.

JUNE 2013

General Education Track Thursday - Sunday

The general education track will offer courses designed to educate pharmacists on a wide variety of important topics pertaining to the profession of pharmacy practice. Specific courses being offered are Reducing Medication Errors, HIV/ AIDS, and the always-popular offering of Florida Legislative Update. There will also be a Technology course which focuses on disease specific apps which will provide up-todate information on various treatment guidelines.

Consultant Education Track Wednesday - Saturday

The consultant education track will provide pharmacists with the most current information available on various topics that are transforming the profession of pharmacy. The specific topics being offered include Compounding, Alternative Medicine, Women’s Health, Men’s Health, Medication Therapy Management, Nutrition Disorders and Food & Drug Interactions. There are 21 hours available for consultant pharmacists.

sentation. Awards Ceremony Reception: Honor outstanding practitioners during the awards presentation. President’s Breakfast: Attend the Sunday morning installation of new officers. Receptions: Enjoy catching up with your colleagues as the Universities entertain their alumni and friends, and as the FPA Foundation hosts CASINO NIGHT. House of Delegates: Be a delegate or observer and see how important member participation is to the direction of the Association. Student Events: Participate in the Adopt-AStudent Mentor Social and Volleyball Tournament. Students will benefit from interacting with practicing pharmacists, attending student focused continuing education programs and learning first hand about the FPA and how involvement can improve their chosen profession. Call the FPA office and offer to mentor or sponsor a student. PharmPACCE Reception: Purchase a ticket to this reception to support your Political Action Committee. PACCE Golf Tournament: Join us Friday for the PACCE Golf Tournament. Please register early to reserve your space.

Student and Technician Track Thursday – Sunday

Students and Technicians will benefit from interacting with practicing pharmacists and attending student and technician focused continuing education programs. The technician track offers several hours of continuing education on a variety of topics, including the required courses for Florida registration and PTCB renewal: Medication Errors, Pharmacy Law and HIV/AIDS for initial renewal. The student track consists of several hours of fun and exciting continuing education, such as The Career Forum and the NASPA/ NMA Game Show. Students will also have an opportunity to participate in the Patient Counseling Competition and showcase their Poster Presentations.

Pre-Convention Education Wednesday Only

Our traditional Wednesday program will focus on Pharmaceutical Compounding. The FPA Educational Affairs Council discussed offering the compounding program long before the nationwide fungal meningitis outbreak caused by contaminated compounded products. Due to the recent outbreak, it is even more imperative to provide pharmacists with proper education on compounding and protecting patient safety. The compounding conference will offer 6 hours of live continuing education credit. Register for this outstanding program and walk away with valuable knowledge for your pharmacy practice. A separate registration fee is required for the pre-convention program.

JW Marriott Grande Lakes

4040 Central Florida Parkway Orlando, FL 32837 (800) 266-9432 Room Rate: $149 by June 17, 2013 (or once room block full) After this date, reservations are taken on a space or rate available basis.

Special Events

Exhibits: Participate in our grand opening reception in the exhibit hall! Poster Presentations: Browse submissions from pharmacy students. Contact the FPA office for more information if you would like to submit a poster pre-

Flo r i d a P h a r m a c y To d a Y

Target Audience: FPA’s educational activities are designed for pharmacists and pharmacy technicians from all practice settings. • Courses appropriate for pharmacists are designated by an ACPE UAN ending in the letter “P”. • Courses appropriate for pharmacy technicians are designated by an ACPE UAN ending in the letter “T”. Contact Hours: Florida Pharmacy Association is offering

a total of 30 contact hours during Convention. Each course identifies the amount of credit which can be received. The Wednesday pre-convention program offers 6 contact hours. A total of 24 contact hours may be obtained from Thursday through Sunday for General (GCE) or Technician (TECH) continuing education. Reducing Medication Errors and HIV/ AIDS are Florida board approved courses. Twenty-one of the offered 24 hours may be used for Consultant Re-certification (RC). Please see the paragraph below for further information regarding Consultant Re-certification.

Consultant Re-certification: To receive consultant recertification credit for your Florida consultant pharmacist license, you must complete a minimum of 3 hour blocks courses marked RC for partial credit. The RC courses are offered on Wednesday through Saturday. There are 6 RC hours on Wednesday, 3 RC hours on Thursday, 6 RC hours on Friday, and 6 RC hours on Saturday. Florida Board of Pharmacy Consultant Approval Number is 20-887171 and 20-387155. Disclosures: Financial support, if provided, for education-

al activities will be listed in program. Faculty disclosures will be announced to participants at the beginning of each activity.

Handouts: Printed booklets of the handouts are available

for purchase. Handouts will be posted on our website, www.pharmview.com, the week of the conference for you to download, print and bring to the meeting.

CPE Requirements: To earn a statement of credit, participants must submit legibly written and completed attendance cards, voucher codes, and evaluation forms to the FPA registration desk before leaving the convention. Statements of credit will be available for you to download and print six (6) weeks following the meeting. • CE Broker: FPA will upload courses to CE Broker, the continuing education system for the Florida Department of Health. It is the responsibility of the participant to provide the correct pharmacist license number or pharmacy technician registration number. CE Broker offers a reduced subscription rate to FPA members per license cycle. • CPE Monitor: FPA will upload courses to CPE Monitor, which allows you to electronically keep track of CPE credits from ACPE-accredited providers. Visit www.mycpemonitor.net to obtain your e-profile. It is the responsibility of the participant to provide the correct e-profile number and date of birth (MM/DD) prior to the upload. FPA will NOT transfer data once upload is complete. 10

Partial Credit Policy: FPA does not offer partial credit for any CPE activity. Participants must attend the session in its entirety.

Temperature: Please have a sweater or jacket available during the meetings as temperature may vary.

Children: Children under the age of 18 are not permitted in the educational programs at anytime due to insurance liability issues. This includes children in strollers and carriers. FPA Policy on Industry Support: FPA adheres to the US Food & Drug Administration’s policy on industry supported educational activities. The FDA policy requires, among other things, that we conduct the educational program supported by any corporate educational grants independently and without control by the grantor of the program’s planning, content or execution. Furthermore, the programs must be free of commercial bias for or against any product. Waiver Of Liability: Each individual attending FPA’s Annual Meeting assumes all risks associated with his/her attendance and participation in all on-and off-site activities that occur during this time. By registering for this meeting, you agree to indemnify and hold harmless, FPA and its governing bodies, officers and employees from all loss, damage or liability arising out of or related to your attendance and participation at FPA’s Annual Meeting. Cancellation Policy: If cancellation is made in writing 30 days prior to the program a refund will be made less a $10 service charge. If cancellation is made 29-10 days prior to the program, a refund will be made, less a $50 service charge. Cancellation requested in writing after that date will result in credit for another FPA CE program or service valid for one year. Walt Disney World: Special meeting/convention tickets are available to attendees and their guests. Network with your colleagues or reconnect with your friends and family after a day of meetings at the Walt Disney World Resort to be awed, inspired and motivated! Order specially priced Disney tickets by July 8, 2013 to take advantage of prearrival savings. These savings are not available at Theme Park Ticket Windows. Visit www.pharmview.com or www. mydisneymeetings.com/flphan/ to purchase these specially priced Disney Meeting & Convention Tickets! The Florida Pharmacy Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Up to 30 contact hours are available upon successful completion of attendance and evaluation forms. Statements of continuing education will be available for you to download and print in 6 weeks. This is an ACPE application-based** and knowledge-based* activity. Speakers have no relevant financial relationship to the activities. JUNE 2013

Flo r i d a P h a r m a c y To d a Y